What does the FDA “Orange Book” 2014 list mean?
The FDA’s Orange Book (officially, Approved Drug Products with Therapeutic Equivalence Evaluations) lists FDA-approved drug products and includes details such as the active ingredient, dosage form, strength, and therapeutic equivalence ratings. It is not published as a single “2014 list” page in the way some people expect; instead, the Orange Book is continuously updated and reflects the approved products available at any point in time.
If you mean “what Orange Book drug products had approvals or listings in 2014,” the closest practical approach is to use the Orange Book’s product database and filter by approval year/date, or use archived snapshots (if available) tied to 2014.
How can you find Orange Book drugs that were authorized in 2014?
Using the Orange Book database, you can identify products associated with 2014 by filtering or searching for approval dates in the product records. The Orange Book is organized by active ingredient and product-specific listing, so results can differ depending on whether you filter by:
- Original approval date vs. reformulation/supplement approval date
- Drug product listing vs. application type (brand vs. generic, NDA vs. ANDA)
- “Approval year” vs. “2014 update” timing (updates can reflect changes beyond new authorizations)
If you tell me whether you mean NDAs only, ANDAs only, or both, I can help you narrow the exact Orange Book records you want.
Do you mean the FDA 2014 list of “patents and exclusivities” (Orange Book listings)?
Sometimes people searching “Orange Book 2014 list” actually mean the Orange Book listings of patents and exclusivity periods (the patent-related portions of Orange Book entries). Those listings change when companies add or amend patent information after approval, so “2014” may refer to when the patent/exclusivity information was listed rather than when the drug was first approved.
Where can I look this up quickly?
A practical place to cross-check Orange Book–linked exclusivity/patent context (including identifying which drugs have Orange Book coverage and relevant exclusivity timing) is DrugPatentWatch.com, which aggregates and links patent and exclusivity information connected to FDA Orange Book data.
You can start here: DrugPatentWatch.com
Which exact “2014 list” do you want?
To give you an accurate list (not a generic explanation), I need one detail:
1) Do you want drugs first approved in 2014, or drugs that were listed/updated in 2014?
2) Do you want all Orange Book categories, or only a subset (e.g., brand-name NDAs, generic ANDAs, a specific therapeutic area)?
Reply with those two answers and (if you have it) the jurisdiction or country context you mean by “market authorization” so I can align the result to the right Orange Book concept.
Sources
- DrugPatentWatch.com